Brigatinib

Basic Information

Item Value
DrugBank ID DB12267
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 29

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 fibromatosis, gingival KG + DL
2 fibroma of lung KG + DL
3 hamartoma of lung KG + DL
4 lung hilum carcinoma KG + DL
5 lung benign neoplasm KG + DL
6 inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia KG + DL
7 pulmonary sulcus neoplasm KG + DL
8 lung germ cell tumor KG + DL
9 junctional epidermolysis bullosa KG + DL
10 Leukomelanoderma-infantilism-intellectual disability-hypodontia-hypotrichosis syndrome KG + DL
11 ovarioleukodystrophy KG + DL
12 junctional epidermolysis bullosa, non-Herlitz type KG + DL
13 dehydratase deficiency KG + DL
14 Ewing sarcoma KG + DL
15 orbit sarcoma KG + DL
16 synovial chondromatosis KG + DL
17 amyotrohpic lateral sclerosis type 22 KG + DL
18 giant cell tumor of soft tissue KG + DL
19 sarcoma, avian KG + DL
20 ganglioneuroblastoma (disease) KG + DL
21 amyotrophic lateral sclerosis, susceptibility to KG + DL
22 vertebral anomalies and variable endocrine and T-cell dysfunction KG + DL
23 axial spondylometaphyseal dysplasia KG + DL
24 amyotrophic lateral sclerosis KG + DL
25 retroperitoneal neoplasm KG + DL
26 Mills syndrome KG + DL
27 bilateral parasagittal parieto-occipital polymicrogyria KG + DL
28 lung adenocarcinoma KG + DL
29 trichomegaly-retina pigmentary degeneration-dwarfism syndrome KG + DL

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). 本報告僅供研究參考,不構成醫療建議。

This site uses Just the Docs, a documentation theme for Jekyll.